Company intelligence / Profile preview

Halo Labs

Burlingame, California, USAhalolabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Halo Labs developed and commercialized the Aura™ family of particle analyzers, enabling high-throughput, low-volume subvisible particle analysis for biologic drug development and manufacturing. Their technologies are used globally by pharmaceutical companies to accelerate candidate selection, formulation development, quality control, and ensure safety in manufacturing processes. The company's solutions are now part of Waters' portfolio following its acquisition in May 2025.

Modalities: Device
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Halo Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Halo Labs.

Explore the full profile